Evidence map›Paper›PMID 23786523›Full record

ReviewExperimental dermatology2013

A central role for inducible heat-shock protein 70 in autoimmune vitiligo.

Jeffrey A Mosenson, Jonathan M Eby, Claudia Hernandez, I Caroline Le Poole

Open access · bronzeAbstract readReview
In one paragraph

Review in Experimental dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Aetiopathogenesis of Vitiligo.Dermatology practical & conceptual · 2023
    Review
  9. Vitiligo: Current Therapies and Future Treatments.Dermatology practical & conceptual · 2023
    Review
  10. Review
  11. Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Article
  14. Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives.Clinical, cosmetic and investigational dermatology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jeffrey A MosensonDepartment of Pathology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL, USA.
Jonathan M Eby
Claudia Hernandez
I Caroline Le Poole
Loyola University Chicago · USUniversity of Illinois Chicago · US

Funding

Targeting HSP70 in autoimmune vitiligoR01AR054749 · NIAMS · LOYOLA UNIVERSITY CHICAGO · PI LE POOLE, I. CAROLINE · 2008 to 2012
$1.6M
NIAMS NIH HHS R01 AR054749NIAMS NIH HHS R01 AR54749
6 · The paper itself

Abstract

Inducible heat-shock protein 70 (HSP70i) is a protein regulated by stress that protects cells from undergoing apoptosis. Such proteins are marvellously well conserved throughout evolution, which has placed them in the spotlight for helping to understand the intriguing relationship between infection and immunity. In the presence of stress proteins, dendritic cells (DCs) will sense this alarm signal and respond by recruiting immune cells of different plumage to fit the occasion. In times of stress, melanocytes will secrete antigen-bound HSP70i to act as an alarm signal in activating DCs that comes equipped with an address of origin to drive the autoimmune response in vitiligo. Here we pose that if the autoimmune response is funnelled through HSP70i, then blocking the stress protein from activating DCs can lend new treatment opportunities for vitiligo.

Indexed as

Autoimmune DiseasesCancer VaccinesHSP70 Heat-Shock ProteinsHumansMelanocytesMelanomaProteinsVitiligoCancer VaccinesHSP70 Heat-Shock Proteinslysosomal proteinsProteinsautoimmunedendritic celldepigmentationheat-shock proteinmouse modelstressT cell

Identifiers

PMID23786523
PMCPMC3745819
OpenAlexW2081472379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.